P
PBYI
Puma Biotechnology Inc
10.12
-0.17-1.65%After Hours: 10.92 +0.80 +7.87%19:03 10/13 EDT
OPEN/PREV CLOSE10.30/10.20
TODAY RANGE10.28-10.72
VOL377.42K
MARKET CAP543.04M
52 WEEK RANGE4.575-10.72
AVG VOL (3M)319.87K
% TURNOVER0.67%
TURNOVER--
P/E (TTM)20.39
% RANGE4.22%
EPS(TTM)0.5160
P/E(FORWARD)27.68
P/B3.880
BVPS2.711
DIVIDEND--
P/S2.322
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP459.44M
SHARES OUTSTANDING51.62M
NEXT EARNINGS11/04-11/09
FREE FLOAT43.67M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·10/01 09:04
Biotech Stocks At 52-Week Highs - PGEN, EXEL, TWST, HNGE, PBYI
TipRanks·09/18 16:31
Puma Biotechnology Advances Alisertib Combo Trial in Small Cell Lung Cancer
TipRanks·09/17 23:40
Closing Bell Movers: Steel Dynamics, Nucor down on pre-announcement
TipRanks·09/17 20:10
Puma Biotechnology starts Phase 2 study of alisertib in small cell lung cancer
NASDAQ·09/09 15:30
Axsome (AXSM) Down 3.7% Since Last Earnings Report: Can It Rebound?
Seeking Alpha·09/08 15:07
Puma Biotechnology: NERLYNX Funds Their Potential Next Oncology Franchise
TipRanks·08/19 00:11
Puma Biotechnology Earnings Call Signals Profitable Momentum
Simply Wall St·08/08 02:45
Puma Biotechnology (PBYI) Stock Jumps On Profit Strength As Earnings Outlook Fades
Dow Jones·08/07 21:18
Puma Biotechnology Is Maintained at Hold by TD Cowen
Benzinga·08/07 21:08
TD Cowen Maintains Hold on Puma Biotechnology, Raises Price Target to $6
TipRanks·08/07 13:26
Puma Biotechnology price target raised to $6 from $5 at TD Cowen
TipRanks·08/06 20:32
Puma Biotechnology sees Q3 revenue $56M-$59M
Same Industry
Name/Symbol
Change%
Price